1. Home
  2. DAR vs IBRX Comparison

DAR vs IBRX Comparison

Compare DAR & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Darling Ingredients Inc.

DAR

Darling Ingredients Inc.

HOLD

Current Price

$65.23

Market Cap

9.7B

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.46

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAR
IBRX
Founded
1882
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.2B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
DAR
IBRX
Price
$65.23
$8.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
7
Target Price
$65.82
$12.57
AVG Volume (30 Days)
2.5M
8.4M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.71
EPS
3.24
N/A
Revenue
$6,135,877,000.00
$113,288,000.00
Revenue This Year
$7.78
$88.59
Revenue Next Year
$3.37
$131.15
P/E Ratio
$20.52
N/A
Revenue Growth
7.36
668.31
52 Week Low
$29.15
$1.95
52 Week High
$69.98
$12.43

Technical Indicators

Market Signals
Indicator
DAR
IBRX
Relative Strength Index (RSI) 50.49 57.26
Support Level $57.88 $6.68
Resistance Level $69.31 $8.51
Average True Range (ATR) 2.38 0.40
MACD -0.21 0.02
Stochastic Oscillator 51.71 68.10

Price Performance

Historical Comparison
DAR
IBRX

About DAR Darling Ingredients Inc.

Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: